Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurochemistry of Drug Addiction With PET
NCT02817698Phase 1Completed
- Sponsor
- Yale University
- Start
- Nov 2017
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Yale University. Primary endpoints: Change in Dopamine Levels at Baseline and After Drug of Dependence Administration at 90 minute and Change in Beta Endorphin Levels at Baseline and After Drug of Dependence Administration at 120 minute. Started Nov 2017; status: completed.
Beyond the preview
Go deeper on NCT02817698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02817698.